SOURCE-LINKED STUDY SUMMARY
Efficacy of icariin in polycystic ovary syndrome: Cathepsin S as a key target revealed by computational and experimental evidence.
Abstract summarizedQuality not appraised
- What was studied
- Combined computer analyses and an animal experiment investigating icariin in polycystic ovary syndrome.
- Who / model studied
- Mice with DHEA-induced polycystic ovary syndrome, with measurements in ovarian granulosa cells. Mouse numbers, comparator details and treatment duration are not stated.
- Studied dose & schedule
- Dose and schedule have not yet been extracted for this summary.
- What the study found
- Icariin-treated mice had lower testosterone, more regular reproductive cycles, fewer cystic follicles and more corpora lutea. Cathepsin S expression decreased in ovarian cells. Computer simulations identified this protein as a possible target; additional pathway changes came from virtual predictions.
- Limitations & context
- Study limitations were not stated in the abstract. Methodological quality has not been appraised.
Read summary source ↗ · Prepared 9/16/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1016/j.bioorg.2026.110474